Seelos Therapeutics received notice that the Nasdaq Hearings Panel had determined to delist the company’s common stock from Nasdaq due to the company’s failure to comply with the minimum stockholder’s equity requirement. Trading in the company’s common stock will be suspended on Nasdaq effective with the open of business on October 16. As a result, the company expects its common stock to begin trading on the OTCQB on that date.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SEEL:
- Seelos Therapeutics trading halted, news pending
- Biotech Alert: Searches spiking for these stocks today
- Seelos Therapeutics Announces Reverse Stock Split and Adjustments
- Morning Movers: Flutter gains after $5B share repurchase program announcement
- Seelos Therapeutics announces 1-for-16 reverse stock split